Phillip M, Mathieu C, Lind M, Araki E, et al. Long-Term Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes: Pooled 52-Week Outcomes from the DEPICT-1 and -2 Studies. Diabetes Obes Metab 2020 Nov 4. doi: 10.1111/dom.14248.
PMID: 33145944